AbbVie Inc.
METHODS FOR TREATING SPINAL CORD INJURY AND PAIN

Last updated:

Abstract:

Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat spinal cord injury, including promoting axonal regeneration, functional recovery, or both and to treat pain, including neuropathic pain arising from spinal cord injury.

Status:
Application
Type:

Utility

Filling date:

9 Mar 2021

Issue date:

27 Jan 2022